Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 129Neoplasm Metastasis 33Glioblastoma 24Melanoma 22Lung Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 15Glioma 12Small Cell Lung Carcinoma 8Neoplasms 8Gliosarcoma 8Central Nervous System Neoplasms 7Neuroma, Acoustic 6Meningioma 6Carcinoma, Renal Cell 6Astrocytoma 5Spinal Cord Neoplasms 4Recurrence 4Sarcoma 3Oligodendroglioma 3Gastrointestinal Neoplasms 3Breast Neoplasms, Male 3Uveal Melanoma 2Radiation Injuries 2Prostatic Neoplasms 2Kidney Neoplasms 2Fatigue 2Depression 2Colorectal Neoplasms 2Anxiety Disorders 2

Interventions

Specimen Handling 1Radiosurgery 1Nivolumab 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Radiosurgery × CNS × Clear all
NCT02978404 2024-06-28

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
26 enrolled
CNSDermatologicGenitourinaryThoracic

Clear-cell metastatic renal cell carcinoma, Brain Neoplasms, Melanoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡